v3.26.1
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
ATM Facility
Public Offering
Private Offering
Series A Warrants
Private Offering
Series B Warrants
Private Offering
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series 1C
Common Stock
Common Stock
Public Offering
Common Stock
Private Offering
Common Stock
Series 1C Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
ATM Facility
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
Private Offering
Additional Paid-In Capital
Series A Warrants
Private Offering
Additional Paid-In Capital
Series B Warrants
Private Offering
Additional Paid-In Capital
Series 1C Preferred Stock
Accumulated Deficit
Other Accumulated Comprehensive Loss
Beginning balance at Dec. 31, 2024 $ 3,379,923           $ 5 $ 815 $ 145       $ 494,983,561             $ (491,608,710) $ 4,922
Beginning balance (in shares) at Dec. 31, 2024             48,100   1,454,896                        
Proceeds from sale on ATM facility   $ 680,863             $ 26       680,837                
Proceeds from sale on ATM facility (in shares)                 249,262                        
ATM facility costs/Private offering costs   (22,943)                       $ (22,943)              
Share-based compensation 211,273                       211,273                
Share-based compensation (in shares)                 1,819                        
Net Income (Loss) (1,674,296)                                     (1,674,296)  
Foreign Currency Translation Adjustment 2,498                                       2,498
Ending balance at Mar. 31, 2025 2,577,318           $ 5 815 $ 171       495,852,728             (493,283,006) 7,420
Ending balance (in shares) at Mar. 31, 2025             48,100   1,705,977                        
Beginning balance at Dec. 31, 2024 3,379,923           $ 5 815 $ 145       494,983,561             (491,608,710) 4,922
Beginning balance (in shares) at Dec. 31, 2024             48,100   1,454,896                        
Net Income (Loss) (3,739,693)                                        
Ending balance at Jun. 30, 2025 3,434,064           $ 5 815 $ 268       498,769,440             (495,348,403) 12,754
Ending balance (in shares) at Jun. 30, 2025             48,100   2,684,651                        
Beginning balance at Mar. 31, 2025 2,577,318           $ 5 815 $ 171       495,852,728             (493,283,006) 7,420
Beginning balance (in shares) at Mar. 31, 2025             48,100   1,705,977                        
Proceeds from sale on ATM facility   1,145,731             $ 46       1,145,685                
Proceeds from sale on ATM facility (in shares)                 471,674                        
ATM facility costs/Private offering costs   $ (45,838) $ (327,303)                     $ (45,838) $ (327,303)            
Exercise of prefunded warrants                             355,722            
Share-based compensation 404,219                       404,219                
Net Income (Loss) (2,065,397)                                     (2,065,397)  
Foreign Currency Translation Adjustment 5,334                                       5,334
Common stock     633,208             $ 51         633,157            
Common stock (in shares)                   507,000                      
Prefunded warrants     355,722                                    
Warrants     $ 751,070                       $ 751,070            
Ending balance at Jun. 30, 2025 3,434,064           $ 5 $ 815 $ 268       498,769,440             (495,348,403) 12,754
Ending balance (in shares) at Jun. 30, 2025             48,100   2,684,651                        
Beginning balance at Dec. 31, 2025 3,337,849           $ 5   $ 466       502,766,029             (499,441,465) 12,814
Beginning balance (in shares) at Dec. 31, 2025             48,100 726 4,662,208                        
ATM facility costs/Private offering costs       $ (799,284)                       $ (799,284)          
Exercise of prefunded warrants 98               $ 142       (44)                
Exercise of prefunded warrants (in shares)                 1,420,047                        
Exercise of warrants 6,706,671               $ 293       6,706,378                
Exercise of warrants (in shares)                 2,923,417                        
Exercised PIPE warrants cost (Note 10) (401,267)                       (401,267)                
Share-based compensation 87,399                       87,399                
Share-based compensation (in shares)                 1,669                        
Net Income (Loss) (2,177,162)                                     (2,177,162)  
Foreign Currency Translation Adjustment (1,671)                                       (1,671)
Common stock       1,200,759             $ 45         1,200,714          
Common stock (in shares)                     454,546                    
Prefunded warrants       $ 3,602,201                       $ 3,602,201          
Warrants         $ 3,878,986 $ 1,317,977                     $ 3,878,986 $ 1,317,977      
Ending balance at Mar. 31, 2026 16,752,556           $ 5   $ 946       518,359,089             (501,618,627) 11,143
Ending balance (in shares) at Mar. 31, 2026             48,100 726 9,461,887                        
Beginning balance at Dec. 31, 2025 $ 3,337,849           $ 5   $ 466       502,766,029             (499,441,465) 12,814
Beginning balance (in shares) at Dec. 31, 2025             48,100 726 4,662,208                        
Exercise of options (in shares) 38,665                                        
Net Income (Loss) $ (4,003,746)                                        
Ending balance at Jun. 30, 2026 15,270,047           $ 5   $ 982       518,703,372             (503,445,211) 10,899
Ending balance (in shares) at Jun. 30, 2026             48,100 665 9,816,431                        
Beginning balance at Mar. 31, 2026 16,752,556           $ 5   $ 946       518,359,089             (501,618,627) 11,143
Beginning balance (in shares) at Mar. 31, 2026             48,100 726 9,461,887                        
Conversion of shares                       $ 3             $ (3)    
Conversion of shares (in shares)               (61)       28,343                  
Exercise of warrants 224,284               $ 29       224,255                
Exercise of warrants (in shares)                 292,014                        
Share-based compensation 89,605                       89,605                
Exercise of options 30,430               $ 4       30,426                
Exercise of options (in shares)                 34,187                        
Net Income (Loss) (1,826,584)                                     (1,826,584)  
Foreign Currency Translation Adjustment (244)                                       (244)
Ending balance at Jun. 30, 2026 $ 15,270,047           $ 5   $ 982       $ 518,703,372             $ (503,445,211) $ 10,899
Ending balance (in shares) at Jun. 30, 2026             48,100 665 9,816,431